Collectively, our findings suggest that CD73+CD8+ T cells express elevated levels of activating markers and reduced levels of inhibitory receptors, positioning them as highly activated and low exhausted T cells in DLBCL patients. This evidence concerns the gene CD8A and diffuse large B-cell lymphoma.